Artificial venous valve containing therapeutic agent

• US 8,303,648 B2
• Filed: 04/24/2007
• Issued: 11/06/2012
• Est. Priority Date: 04/25/2006
• Status: Active Grant

• Current Assignee: Cook Medical Incorporated (Cook Group Incorporated)
• Original Assignee: Cook Medical Incorporated (Cook Group Incorporated)
• Inventors: Grewe, David D., Purdy, James D.
• Primary Examiner(s): Koharski, Christopher D
• Assistant Examiner(s): STEWART, JASON-DENNIS NEILKEN
• Application Number:
  US11/789,413
• Publication Number:
  US 20070265699A1
• Time in Patent Office: 2,023 Days
• Field of Search: 623/1.24, 623 21- 219, 623 142- 143
• US Class Current: 623/1.24
• CPC Class Codes: A61F 2/2412 with soft flexible valve members, e.g. tissue valves shaped like natural valves check valves with flexible valve members in general F16K15/14
• CPC Class Codes: A61F 2/2418 Scaffolds therefor, e.g. support stents
• CPC Class Codes: A61F 2/2475 Venous valves
• CPC Class Codes: A61F 2220/0016 with sharp anchoring protrusions, e.g. barbs, pins, spikes
• CPC Class Codes: A61F 2220/005 using adhesives
• CPC Class Codes: A61F 2220/0058 soldered or brazed or welded
• CPC Class Codes: A61F 2230/0026 trapezoidal
• CPC Class Codes: A61F 2230/0095 Saddle-shaped
• CPC Class Codes: A61F 2250/0068 the pharmaceutical product being in a reservoir

Abstract

The invention relates to a prosthetic valve for regulating flow through a body lumen and delivering a therapeutic agent into said lumen. In one embodiment, the prosthesis includes a frame having an exterior wall, a hollow interior space, a valve member, and at least one aperture through the exterior wall that permits a controlled amount of therapeutic agent loaded into the hollow interior into the surrounding body lumen following implantation. In another embodiment, the prosthesis includes a frame having a groove, a valve member, and therapeutic agent loaded in the groove.

Claims

1. An implantable valve prosthesis comprising:

a frame having compressed and expanded configurations, the frame comprising an exterior wall and a frame segment having an axial length, the exterior wall defining a hollow interior space surrounded by the exterior wall and extending continuously through the frame segment along the axial length, the exterior wall further defining at least one aperture defining a conduit extending through the exterior wall to the hollow interior space;

a valve member operatively connected to the exterior wall and having first and second opposing sides and first and second opposing ends, the first side, second side, and second end being continuously attached to the frame by being wrapped around and surrounding a portion of the frame that includes the frame segment such that the hollow interior space and the at least one aperture are positioned under the wrapped portion of the frame, the first end being free of the frame, the valve member adapted to modify fluid flow through a body lumen; and

a therapeutic agent loaded in the hollow interior space in such a way so that at least a portion thereof may pass through the at least one aperture and the valve member.

2. The prosthesis of claim 1, wherein the therapeutic agent is selected from the group consisting of anti-inflammatory/immunomodulators, antiproliferatives, migration inhibitors/ECM-modulators, antithrombotics, and thrombolytics.

3. The prosthesis of claim 1, wherein the therapeutic agent is heparin.

4. The prosthesis of claim 1, wherein the therapeutic agent is hirudin.

5. The prosthesis of claim 1, wherein the valve member comprises a biocompatible material which is operatively connected to the exterior wall such that the biocompatible material substantially encapsulates the at least one aperture.

6. The prosthesis of claim 1, wherein the valve member comprises a biocompatible material which is operatively connected to the exterior wall such that the biocompatible material substantially encapsulates the frame.

7. The prosthesis of claim 1, wherein the frame is selected from the group consisting of stainless steel, nitinol, tantalum, a nonmagnetic cobalt-chromium alloy, platinum, titanium, a suitable biocompatible alloy, a suitable biocompatible polymer, a suitable biocompatible material, and a combination thereof.

8. The prosthesis of claim 1, wherein the at least one aperture is between about 0.0001 inches and about 0.010 inches wide.

9. The prosthesis of claim 1, further comprising:

a reservoir for containing therapeutic agent to be delivered to the frame hollow interior; and

a transport device for dispensing therapeutic agent from the reservoir to the hollow interior;

wherein the transport device comprises a proximal end operatively connected with the reservoir and a distal end operatively connected to the hollow interior to facilitate the delivery of the therapeutic agent to the hollow interior through the transport device.

10. The prosthesis of claim 9, wherein the reservoir comprises biocompatible polyurethane.

11. The prosthesis of claim 1, wherein the therapeutic agent is further loaded in the at least one aperture.

12. The prosthesis of claim 1, wherein the valve member comprises a porous polymer.

13. The prosthesis of claim 12, wherein the polymer defines pores that are at least 0.0001 inches wide.

14. The prosthesis of claim 1, wherein the valve member comprises a non-porous polymer.

15. The prosthesis of claim 14, wherein the non-porous polymer has pores cut therein.

16. The prosthesis of claim 15, wherein the pores are at least 0.0001 inches wide.

17. The prosthesis of claim 1, wherein the hollow interior space extends through the entire frame.

18. The prosthesis of claim 17, wherein the entire frame is covered by the valve member.

19. The prosthesis of claim 1, wherein the entire hollow interior space is positioned under the wrapped portion of the frame.

20. The prosthesis of claim 19, wherein the entire frame is covered by the valve member.